| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.08 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.058 | 0.08 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.08 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.1 | 0.08 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.09 | 0.08 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.08 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.08 |